The present studies were designed to determine effects of a microgravity model system upon lipopolysaccharide (LPS) stimulated tumor necrosis factor alpha (TNF-alpha) activity and indices of insulin and fuel homeostasis of pancreatic islets of Langerhans. Islets (1726±1 17, 150 u IEU) from Wistar Furth rats were treated as: 1) HARV (High Aspect Ratio Vessel cell culture)
INTRODUCTION
Factors which modulate glucose tolerance and hyperglycemia in diabetes, and it's related syndromes include pancreatic islet insulin secretory function, hepatic and peripheral insulin sensitivity, and glucose effectiveness (7, 42, 16 ). An intriguing candidate peptide which has recently been implicated in the glucose intolerance of diabetes and obesity, is the cytokine tumor necrosis factor-alpha (TNF-alpha). TNF-alpha is a potent modulator of insulin sensitivity in adipocytes (1, 13) . Increased TNF-alpha induces peripheral insulin resistance which can decrease glucose utilization. While it was once believed that macrophages and adipocytes were the primary sites of TNF-alpha production, we have recently demonstrated that purified pancreatic islets of Langerhans are a potent source of TNF-alpha (20) . These observations suggest a putative islet-linked site of action for TNF-alpha in glucose intolerance.
Prolonged bedrest has long been utilized as a paradigm for insulin resistance and glucose intolerance; it also resembles metabolic alterations observed in microgravity (29) . Human bedrest studies (21, 22) demonstrate increased peripheral tissue insulin resistance and reduced glucose tolerance. Similarly, post-flight investigations of cosmonauts (12) after free-fall orbit demonstrate increased plasma glucose and decreased glucose tolerance. Other space-flight investigations iliustrate aitered C-peptide excretion (33) and insulin resistance (R) during earth orbit. These observations and others (24) suggest that bedrest and in-flight experiments support similar-ohanges to that observed in the glucose intolerance .of.pre-diabetes, aging, physical inactivity or obesity.
A series of in vitro studies illustrate altered immune cell cytokine activity in microgravity which may favor increased insulin resistance via altered TNF-alpha release. The SL-3 mission demonstrated that immune responses may be altered by space flight (32). On STS-56, MC3T3-E 1 osteoblasts activated in microgravity utilized less glucose and had reduced prostaglandin E 2, a proposed regulator of cytokine production (15) . As little as eight seconds of microgravity has been demonstrated to alter macrophage responses (2) . Lipopolysaccharide (LPS) activated macrophages secrete more IL-1 and TNF-alpha when stimulated in microgravity than on earth (6). These space flight studies may provide insight into a mechanistic link between immune modulations and glucose tolerance. However, serious questions remain as to which . observations
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While there is disagreement as to whether ground-based paradigms truly simulate microgravity (38), certain cell culture systems provide a model system for investigating altered gravity effects. One such microgravity model system is the High Aspect Ratio Vessel (HARV), developed at the Johnson Space Center. The HARV is a self contained horizontally rotating cell.
culture system that allows for diffusion of oxygen and carbon dioxide across a semi permeable membrane. The HARV demonstrates a very low shear stress (0.5 dynes/cm-) for one or two mm cellular aggregates (38) . It has a time-averaged gravity vector of 10 -2 g (31) as compared to that of near-earth free-fall orbit which is 10' -10 -6 g. Thus, the HARV is a useful paradigm for studying cellular physiology in a ground based, cell culture system, which demonstrates both low shear stress and a gravity averaged free-fall paradigm.
The present studies were designed to determined the main and interactive effects of microgravity and addition of LPS on TNF-a activity, insulin secretion and glucose concentrations in cultured islets of Langerhans. An additional aim was to determine alterations in amino acid and nitrogenous compound utilization as an explanation for altered glucose concentrations in the microgravity model system. All animals were acclimatized to the laboratory for one to two weeks prior to beginning experiments. We removed food from the cages of donor male Wistar Furth rats at approximately 1800 h: at 0800 h the following morning (day 1, Fig. la ) the rats were anesthetized with 55 mg/kg sodium pentobarbital i.p., and pancreatectomized. Animals were exsanguinated under surgical anesthesia following pancreatectomy. Islets were isolated using established methods (3), with modifications previously described (11) . Purified islets were hand picked to obtain approximately 1700 islets per treatment group, using 25x magnification with a green illuminated background and white fiber optic side illumination.
SUBJECTS AND

Static Culture of Islets Following Islet Isolation: Day 1, 2
FFe hl-yd*solated islets -of.Langerhans,:vyere,placed into ^Qdium-199 (with additional 100 U/ml penicillin, 100 µg/ml streptomycin, 10% fetal bovine serum, 25 mmoles/1 Hepes buffer, 0.68 mmoles/1 L-glutamine) as previously described (11) . Islets were isolated over a two day period. The islets from two rats each (6 rats per day of isolation), were placed into 6-well polystyrene culture plates with 10 ml Medium-199 per well (approx. 1200 islets). Islets were introduced into static culture at approximately 1700 hrs. Islets remained on static culture for 24 -48 hours prior to being aliquoted into HARV cultures for experiments HARV Cell Culture Techniques for Pancreatic Islets: Day 3, 4 Islets were aspirated from culture plates and cells were transferred into one 50 ml conical vial and brought to 40 cc with M-199. Islets from all pancreatic isolations were mixed, then aliquoted into 4, 15 ml conical vials and centrifuged at 1000 rpm. The vials were vortexed, and aliquots of 100 ul (3x) were removed for determination of islet diameter, which was estimated according to standards established by Ricordi and colleagues (30). A one ml sample was obtained and designated as 0 HRS (Study A) and frozen at -70° C.
Islets (1726±1 17, 150 u IEU) were aliquoted into 2, 10-m1 High Aspect Ratio Vessels (HARV, Synthecon, Houston) and into culture plate wells and were placed into a 5% CO 2, 95% humidified, 37° C incubator. The initial HARV speed was set at approximately 12 revolutions per minute. All bubbles were carefully removed from the HARVS prior to initiating revolutions.
Preparation for LPS Stimulation: Dav 5 Following 48 hours of HARV or static culture, 1 ml of islet media was aliquoted for analvsis and designated as 48 HRS (Study A). Both HARV and static cultures had 5 ml freshly prepared Medium-199 added to bring the total volume to 10 ml. All subsequent samples were taken by isovolumetric techniques. In the HARV, this was accomplished by infusing 300 uL of Islets were obtained from HARV and static cultures for image analysis by phase contrast and confocal microscopy. Representative images islets of Langerhans from the initial static culture period (day 3), and islet cells cultured in HARVs (day 5) were obtained on a Hund Willovert S inverted microscope equipped with phase contrast optics, a green filter, and white fiber optic side illumination. Islets were maintained in culture medium and images were acquired using a Cannon EOS IN 35mm camera and a 40x air objective.
Sample Anal
Tumor Necrosis Factor Assay: The L929 mouse fibroblast assay, as previously described (18, 19, 20) , was used to measure islet medium TNF activity. Briefly, L929 cells were grown to confluence overnight in 96 well culture plates; Actinomycin-D (5 µg/ml; Merck Sharp & Dolune, Weston, PA) was added to each well and serial dilutions of experimental islet medium were added to duplicate L929 wells. Following incubation, adherent L929 cells were stained with 0.5% crystal violet, optical density of each well was spectrophotometrically measured and % cytotoxicity of L929 cells was determined (27). TNF activity was then converted to Units/ml (U/ml); one unit of TNF activity was defined as equal to 50% L929 cytotoxicity in the appropriate dilution of islet medium. Dose-response inhibition of TNF activity using rat-specific TNF-alpha antibodies (Endogen Inc., Boston, MA) were performed on islet medium samples to confirm that L929 cytotoxicity was due to TNF-alpha activity.
Insulin Analysis: Islet medium was diluted 1:500 in Medium-199, and insulin was determined by..competitive binding radio 1mmunoassay(LI _ . St. _Charles, MO with antibodies -).
raised against rat insulin and using rat insulin standards (25) . Prior determination of the withinassay coefficient of variation for 8 assays of pooled rat plasma was estimated at 6.2%.
Glucose and Lactate Analysis:
Samples were analyzed in duplicate as is or diluted 1:10 with distilled water for glucose and lactate analysis using a YSI 2300 Stat Plus Analyzer (Yellow Springs Instruments, Yellow Springs OH). 
RESULTS
Pancreatectomy and Islet Isolation
Islets were isolated from living pancreas donors and were placed into cell culture within 5 hours following pancreatectomy. Five complete experiments were performed on separate islet populations, with four treatment groups per experiment for Study A; a subset of four islet populations per treatment were studied in Study B. There were no significant differences for the 150 micron islet equivalent mass in the islet populations between experimental groups (p>0.05, 
LPS Stimulated-TGIF-alpha Production
Prior to LPS stimulation there were no significant differences in L929 TNF-alpha cytotoxicity for any treatment group in any statistical measure (Fig 2a) .
Following stimulation with LPS there were significant increases in TNF-alpha of both static and HARV cultured cells (Fig 2b) . Three-way repeated measures ANOVA indicated significant between-subjects effects for METHOD (p=0.0049, static culture > HARV), LPS (p=0.0001, LPS > non-LPS), and HARV*LPS (p =0.0046, static culture LPS > HARV LPS).
Within-subjects effects were significant for TIME (p=0.0001) and an interaction of HOURS*LPS (p=0.0001). Islets stimulated with LPS in static culture retained a significantly greater TNF-alpha concentration vs LPS stimulated HARV cultures throughout the entire 48 hours of the study. There were no significant changes in TNF-alpha among control cultures.
Insulin Concentration
At time zero, insulin concentrations were less than 100 nmoles/l, and were not significantly different between HARV and static culture treatment groups (Fig 3a) . Repeated measures ANOVA indicated a significant effect of TIME (p=0.0004, 48 HRS > 0 HRS).
Following 48 hours of culture, there was greater than a 3-fold increase in immunoreactive rat insulin concentrations. However, there were no significant differences between HARV and static cultures at 48 hours.
There was a marked linear increase in the insulin concentration of both HARV and static culture islets which were not stimulated with LPS (Fig 3b) . 
Glucose Concentration
Prior to cell culture, there were no significant differences in the amount of glucose in islet medium between HARV or static culture groups (Fig 4a) . Two-way repeated measures ANOVA demonstrated a significant interaction of Time and Method (p=0.0488). The media from islets in the PLATE culture had the lowest glucose concentration at 48 hours (p<0.05).
Following stimulation with LPS, there were relatively minor differences in the media glucose concentration up to 12 hours of culture (Fig 4b) . Repeated measures ANOVA indicated a significant effect of METHOD (p=0.0203, HARV > static culture). The within-subjects effect of HOURS was also significant (p=0.0026). At 48 hours post LPS stimulation, the static culture group had metabolized the greatest amount of glucose from the media. The highest media glucose concentrations were observed in the non LPS-stimulated HARV cultures, which were significantly different from the LPS stimulated static culture islets.
Lactate Concentration
Media lactate concentrations increased during the initial 48 hour culture period to a level which was significantly different froin the zero hour value (Fig 5a) . Repeated measures ANOVA illustrated a significant effect of TIME (p=0.0001, 48 HRS > 0 HRS). However, there were no significant differences between the lactate concentrations of HARV or static culture groups.
During the LPS stimulation studies, all treatment groups increased their lactate concentrations (Fig 5b) . Repeated measures ANOVA indicated a significant main effect only for TIME (p=0.0001). At 48 hours of study, there were no significant differences between groups.
Amino Acid / Nitrot7enous Metabolite Concentrations
Amino acids and nitrogenous analytes were arranged into functional groupings and are depicted in There were no significant differences in LDH values at any time point in Study B (Table  2 ). Repeated measures ANOVA with interaction determined significant between-subjects overall effects of METHOD (HARV<PLATE, P=0.0505). Within-subjects analysis was significant for TIME only (p=0.001).
HARV Generated Islet Cell Aggregates (ICAs)
Phase contrast microscopy of isolated islets of Langerhans cultured on static plates for 24-48 hours, illustrates intact islets with apparently intact collagen capsules, as well as soiree freely circulating cells from islets which were over digested (Fig. 6a ). Following forty-eight hours of HARV culture, cellular aggregation is apparent as a ubiquitous phenomenon in ICAs cultured in the microgravity model system (Fig. 6b) . A prominent capsular appearance in the periphery of the matrix of ICAs is apparent.
DISCUSSION
The present studies were designed to investigate the influence of the HARV microgravity model system and LPS administration upon 'FNF-alpha production of pancreatic islets of Langerhans and elucidate related changes in insulin and glucose homeostasis. Studies were designed to determine the independent influence of cell culture method and LPS stimulation upon TNF-alpha activity and hormonal production, and elucidate potential interactions between these variables. Additionally, investigation of nitrogenous analytes were performed to elucidate all for glucose and lactate data. The current studies demonstrate five novel observations: 1) LPS induced TNF-alpha production is lesser in the HARV islet media, than in static cultures, 2) the increase in TNF-alpha is associated with a lesser basal insulin secretion especially in HARV cultures, 3) islets cultured with the HARV are associated with a lesser glucose consumption, than are islets from static culture, 4) HARV islets demonstrate an equimolar increase in the utilization of arginine and production of ornithine, and 5) islets cultured with HARVs, will aggregate into "tissue like units", which we will designate as "Islet
Cell Aggregates" (ICAs).
A most interesting and novel result in our present study is that isolated islet preparations in HARVs had increased TNF levels with exposure to LPS indicating that TNF-producing cells are present in ICAs and that LPS stimulates TNF secretion in these islets. Our present studies indicate-possible. involvement of TNF at the site of insulin, secretion, the, p9 -t}creali i slets of rats.
Others have suggested that TNF gene expression may be located in the pancreas and may play a Sansum. They noted that fewer than 1% of islet immune cells in this strain were macrophages and suggested that TNF-alpha may be produced by islet T cells during an autoimmune reaction in the islets of this diabetic mouse. Our data provides further evidence that islets can be sites of TNF secretion in rats. We believe this is an intriguing observation with respect to islet secretory
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That TNF-alpha is associated with a decreased basal insulin secretion is intriguing, both as it relates to in-flight extrapolations, ground based bed rest models, and as it suggests insight into the pathophysiology of Type 1 and Type 2 diabetes mellitus. In-flight studies during the Skylab mission (17) plasma glucose values were also decreased in Skylab crewmembers, suggesting improved glucose control. -However, the Skylab data have been viewed as conflicting; since a sharp drop in insulin was followed with a trend towards an increase, which was subsequently followed weeks later by a spike in insulin during the third and forth weeks of flight (26). This could occur if there were a compensatory increase in insulin production secondary to reduced insulin sensitivity as suggested by Stein (33); however, this would have to occur in a time-dependent process with pancreatic function reacting secondarily and/or primarily to spaceflight stressors. The present studies raise the possibility of an endogenously mediated decrease in insulin secretion, as a secondary consequence of altered cytokine production in the HARV microgravity model system.
That a lowest basal insulin secretion was observed in LPS stimulated HARV cultures, is a novel observation, and suggests that islet derived TNF has a potent capacity to down regulate islet insulin secretion in microgravity model systems. We hypothesize that this reduction in insulin secretion occurs at a lower media concentration of TNF-alpha in the HARV, than is observed in the static plate controls, possibly due to higher intracellular concentrations of TNF in the ICAs.
This hypothesis is currently under investigation in ongoing studies.
Ground based-bed rest studies support the hypothesis of a progressive increase in insulin resistance, which is accompanied by a decrease in muscle mass following prolong physical inactivity (4). TNF has not been related to this effect, but has been suggested as a mechanism of obesity induced insulin resistance, which may accompany decreased activity levels (1, 14) .
Others have suggested that TNF may play a direct role in islet cell function during the autoimmune response in the development of insulin-dependent diabetes mellitus. Duager et al. (9) found that direct TNF exposure inhibited insulin secretion and caused significant DNA strand breakage in isolated rat islets. Others reported that TNF attenuated islet cell function and proposed that direct stimulation by TNF may be involved in modulation of insulin secretion from alpha cells during the progressive autoimmune development of insulin-dependent diabetes mellitus. The pathophysiology of Type 2 diabetes mellitus is known to involve a decrease in insulin sensitivity, an initial compensatory hyperinsulinemia, followed by a subsequent decline in pancreatic insulin secretion (7) . When sequentially combined, these events promulgate hyperglycemia. The influence of TNF-alpha in peripheral insulin resistance of adipose tissue has been implicated in the pathophysiology of Type 2 diabetes (13, 14) . The present studies provide an additionaL_,nlechanism by which islet derived TNF-alpha m contribute to the development of Type 2 diabetes by suppressing insulin secretion and promulgating hyperglycemia. The clinical relevance of these observations is unknown. The consistent increase in media insulin concentration, and the similar LDH activity of all groups, demonstrates two measures of cell viability throughout the study.
It has been proposed that insulitis with inflammatory cell influx into islets is responsible for any islet expression of TNF which may then influence islet function. While macrophages are present in islets and may be producing TNF in response to LPS, we propose that other possible sites of TNF production may also exist in the islet infrastructure. The many endocrine cell types located in islets could be possible sources of TNF, but vascular smooth muscle cells of the complex intra-islet vasculature may also be secreting TNF. In previous studies (27), we have shown that human blood vessels can be a significant source of TNF. We found that when stimulated with LPS, the time-dependant release of TNF from human vascular tissue was significantly increased compared with time-matched non-stimulated control vascular tissue. In human smooth muscle cells cultured from both internal mammary arteries and saphenous veins, the release of'INF into the medium essentially mimicked that seen in the intact vascular segments. Our experiments showed that TNF release occurred from both intact blood vessels and smooth muscle cells. Collectively, these findings suggested that at least one source of TNF may be the smooth muscle cell within vascular tissue. Since all islets have afferent arterioles that branch into numerous capillaries to form glomerular-like structures Vdiiell then form an extensive network of peri-insular collecting venules, it is an intriguing possibility that cells, other than macrophages, located in or near such highly vascularized islet beds may also synthesize and or that basal energy expenditure was significantly reduced in the microgravity model system.
The equivalent values in lactate concentration between groups over time indicate this
phenomenon is not explained by altered glycolytic activity. In the basal state 30% of islet metabolic energy requirements are met by the oxidation of the amino acid glutamine (23) .
Glutamine is the most abundant amino acid in the body and plays a primary role as a carrier of nitrogen between organs, with it's amide group used for nucleic acid biosynthesis (41). We there were an increase in insulin resistance during spaceflight which was present during the postprandial state, an increased conversion of arginine to ornithine may modulate a decreased ability for compensatory insulin secretion. The lack of a significant increase in the amino acid citrulline, rules out a more active nitric oxide synthase vs arginase. Thus, nitric oxide production via arginine to citrulline conversion, is likely not greater in the HARV, and islet blood perfusion, vascular reactivity, or membrane integrity is in all likelihood not compromised. The equimolar increase in urea, however, would suggest that an increase in total urea cycle activity is not a plausible explanation for these data. Decreases in lean body mass, and altered amino acid utilization illustrate that nitrogenous metabolites are influenced by spaceflight (34-36). In ground-based studies, the reduction in lean body mass occurs concomitantly with altered glucose and insulin metabolism (21, 22, 29) . At present there is no unified hypothesis to explain these observations, although it has been .suggested-that a_loss of lean_bo_dy-tnass andsubsequent release of nitrogenous metabolites, may be related to an increase in insulin resistance (33). The present a ... studies are the first to document decreased glucose utilization, concomitant with alterations in nitrogenous analyte utilization, respective to an in vitro microgravity model system, and thus, both support and extend the data and hypotheses of Stein (33-36).
The aggregation of isolated islets of Langerhans into ICAs was a serendipitous discovery.
From the four experiments conducted herein, we observed that islet aggregation occurs within 15 hours of HARV culture. That cells will aggregate within the HARV is a well known phenomenon, and has been documented elegantly in a recent review (38). Islet transplantation research currently underway which utilizes a microgravity model system for cell assernbly, is aimed at developing an islet beta cell / sertoli cell aggregate for transplantation in Type 1
Man uscript: E-632-9-R diabetes (5) . The present studies illustrate that approximately 1700 whole islets will aggregate into WAS that measure approximately 3 mm in diameter. The importance of such a large tissue mass may be salient to the success of pancreatic islet transplantation as a cure for Type 1 diabetes mellitus. At present, purified islets of Langerhans have been transplanted intraportally into the liver of Type 1 patients, resulting in normalization of plasma glucose concentrations (40). The requirement for immunosuppresion is contraindicated to effective islet function, as most immunosuppresive agents decrease insulin sensitivity. Sertoli-islet cell aggregates may provide an immunoproviledged graft. However, these cells %vill still need to be transplanted into a highly vascularized organ site such as the liver. The potential of ICAs lies in the possibility of creating a greater tissue mass, with potential vascularization, which can be transplanted into a readily accessible vascularized organ such as the kidney capsule. Such an approach, if combined with sertoli cell technology, would provide a graft that is in1n111nopriviledged and allow for removal of the graft in the presence of rejection. Such options are not currently available for intraportal islet transplants, and at present, recipients of purified islets require lifelong 1 111 111 11 1 1 0SUppreslon. SUCK possibilities are encouraging for ultimate success in the search for a cure for Type 1 diabetes; a cure which ideally will ameliorate the need for daily exogenous insulin administration, and prevent the devastating secondary complications of this disease.
In conclusion, the present studies demonstrated alterations in LPS induced TNF-alpha production of pancreatic islets of Langerhans, favoring lesser .TNF-production in the microgravity model system HARV paradigm. We conclude that rat pancreatic islets are possible sources of TNF during exposure to bacterial LPS and that insulin secretion may be altered by LPS-induced TNF secretion. Our results are most interesting since TNF has been implicated as possibly playing a significant role in the obesity-related development of insulin resistance, glucose intolerance and non-insulin-dependent diabetes mellitus. If one proposes that an infectious agent or even increased levels of circulating lipoprotein or glucose could stimulate TNF secretion within the islet which then may alter insulin secretion, intriguing hypotheses could be developed as to the local production of islet-derived TNF and its action on islet cell function in the whole body. The present studies also illustrated that basal insulin secretion was suppressed concomitant with an increase in TNF-alpha, and may be implicated in hormonal alterations of spaceflight and the pathophysiology of Type 2 diabetes. Fuel homeostasis appears to be different in the HARV culture, as virtually no glucose was utilized in this paradigm, suggesting an alternative fuel source for ICAs. While nitrogenous compound analysis indicated a ubiquitous reliance upon glutamine in all experimental groups, argimne was converted to ornithine at a twofold greater rate in the islets cultured in the HARV microgravity model system. Such a b a FIGURE 6. Phase-contrast photomicrographs of freshly isolated islets of Langerhans from male Wistar Furth rats (6a), and islets cultured for 48 hours in the HARV (6b). All images were obtained using a 40x air objective with a green filter and white fiber optic side illumination..
